shows that the nuclear receptor Nur77 enhances the expression of PCK1 by competitively blocking Ubc9 to inhibit PCK1 sumoylation and by reducing the acetylation activity of p300, thereby promoting gluconeogenesis and inhibiting the progression of HCC (129). This evidence concerns the gene PCK1 and hepatocellular carcinoma.